Style | Citing Format |
---|---|
MLA | Darooee M, Akbari V, Taheri A. "Inhibition of Aldehyde Dehydrogenase by Furazolidone Nanoemulsion to Decrease Cisplatin Resistance in Lung Cancer Cells." Therapeutic Delivery, vol. 12, no. 8, 2021, pp. 611-625. |
APA | Darooee M, Akbari V, Taheri A (2021). Inhibition of Aldehyde Dehydrogenase by Furazolidone Nanoemulsion to Decrease Cisplatin Resistance in Lung Cancer Cells. Therapeutic Delivery, 12(8), 611-625. |
Chicago | Darooee M, Akbari V, Taheri A. "Inhibition of Aldehyde Dehydrogenase by Furazolidone Nanoemulsion to Decrease Cisplatin Resistance in Lung Cancer Cells." Therapeutic Delivery 12, no. 8 (2021): 611-625. |
Harvard | Darooee M, Akbari V, Taheri A (2021) 'Inhibition of Aldehyde Dehydrogenase by Furazolidone Nanoemulsion to Decrease Cisplatin Resistance in Lung Cancer Cells', Therapeutic Delivery, 12(8), pp. 611-625. |
Vancouver | Darooee M, Akbari V, Taheri A. Inhibition of Aldehyde Dehydrogenase by Furazolidone Nanoemulsion to Decrease Cisplatin Resistance in Lung Cancer Cells. Therapeutic Delivery. 2021;12(8):611-625. |
BibTex | @article{ author = {Darooee M and Akbari V and Taheri A}, title = {Inhibition of Aldehyde Dehydrogenase by Furazolidone Nanoemulsion to Decrease Cisplatin Resistance in Lung Cancer Cells}, journal = {Therapeutic Delivery}, volume = {12}, number = {8}, pages = {611-625}, year = {2021} } |
RIS | TY - JOUR AU - Darooee M AU - Akbari V AU - Taheri A TI - Inhibition of Aldehyde Dehydrogenase by Furazolidone Nanoemulsion to Decrease Cisplatin Resistance in Lung Cancer Cells JO - Therapeutic Delivery VL - 12 IS - 8 SP - 611 EP - 625 PY - 2021 ER - |